vimarsana.com

Indian pharmaceutical giant Biocon on Friday reported a net profit of Rs 172.7 crore in the September quarter of financial year 2023-24, more than double its profit of Rs 81.8 crore in the same period of the previous year. According to the compa

Related Keywords

Japan ,United States ,Australia ,Bengaluru ,Karnataka ,India ,New Zealand ,America ,American ,Shreehas Tambe ,Siddharth Mittal ,Biocon Biologics ,Jonathan Hunt ,Manufacturing Services ,Biocon ,Biocon Ltd ,Biocon Biologics Ltd ,North America ,Emerging Markets ,Managing Director Siddharth Mittal ,North American ,Generic Formulations ,Managing Director Shreehas Tambe ,Managing Director Jonathan Hunt ,Quality Control ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.